Cartesian Therapeutics Stock Performance

Cartesian Therapeutics Relative Risk vs. Return Landscape

If you had invested $ 845.00 in Cartesian Therapeutics on December 11, 2025 and sold it today you would have lost $-19.00 from holding Cartesian Therapeutics or given up 2.25% of portfolio value over 90 days. Cartesian Therapeutics is currently generating a 0.1428% daily expected return and assumes 6.2384% risk (volatility on return distribution) over a 90-day horizon. In different words, 55% of stocks are less volatile than Cartesian, and 98% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.This relative risk-return summary reviews how the instrument behaves against its benchmark. It highlights whether the current reward profile compensates for the level of uncertainty assumed. Given the investment horizon of 90 days Cartesian Therapeutics is expected to generate 8.11 times more return on investment than the market. However, the company is 8.11 times more volatile than its market benchmark. It trades about 0.02 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly -0.05 per unit of risk.

Target Price Odds to finish over Current Price

Given the investment horizon of 90 days the stock has the beta coefficient of 2.1 indicating as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Cartesian Therapeutics will likely underperform. Additionally, Cartesian Therapeutics has an alpha of 0.5896, implying that it can generate a 0.5896 percent excess return over Dow Jones Industrial after adjusting for the inherent market risk (beta).

Predictive Modules for Cartesian Therapeutics

There are currently many different techniques concerning forecasting the stock market as a whole, as well as predicting future values of individual instruments such as Cartesian Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.

Hype Prediction Low Estimated High 1.95 8.17 14.39 Details

Intrinsic Valuation Low Real High 7.34 14.95 21.17 Details

Naive Forecast Low Next High 1.72 7.94 14.16 Details

8 Analysts Consensus Low Target High 32.37 35.57 39.48 Details

Please note, it is not enough to conduct a financial or market analysis of a single entity such as Cartesian Therapeutics. Your research has to be compared to or analyzed against Cartesian Therapeutics' peers to derive any actionable benefits.

Cartesian Therapeutics Risk Indicators

The last 10-20 years have been a volatile period for the stock market. Cartesian Therapeutics is no exception. The market experienced several large corrections towards Cartesian Therapeutics' value, including sharp drops and substantial rallies. An investor can limit portfolio swings by implementing a hedging strategy designed to reduce downside losses. If you hold Cartesian Therapeutics, one way to protect your portfolio is to watch for changing volatility and market elasticity of Cartesian Therapeutics within the framework of fundamental risk indicators.

Cartesian Therapeutics Alerts and Suggestions

Automated alerts tied to Cartesian Therapeutics help investors stay ahead of material changes in stock conditions. Monitoring ongoing notifications for Cartesian Therapeutics is a practical way to spot shifts in technical or fundamental signals that may affect investment timing.

Cartesian Therapeutics Price Density Drivers

Cartesian Therapeutics Fundamentals Growth